Challenging Routine Prophylaxis in Unruptured Intracranial Aneurysm Clipping

Microsurgical clipping remains a definitive intervention for intracranial vascular abnormalities. However, surgeons frequently administer prophylactic antiseizure medications to prevent early perioperative convulsions. Although historical protocols favored routine antiepileptic therapy, modern microsurgical advancements have significantly minimized cortical manipulation and vascular disruption. Consequently, clinicians increasingly question the necessity of routine prophylactic anticonvulsants for standard surgical cases. For decades, practitioners feared that acute convulsions might precipitate catastrophic intracranial hemorrhage, arterial rebleeding, or secondary ischemic insults. Nevertheless, antiepileptic agents carry substantial risks, including cutaneous adverse reactions, hepatotoxicity, cognitive sluggishness, and complex pharmacokinetic interactions. In response to these concerns, contemporary surgical teams seek evidence-based criteria to identify patients who can safely avoid medication exposure. A landmark prospective investigation evaluated the safety profile of withholding prophylactic drugs during elective unruptured intracranial aneurysm clipping. This investigation provides compelling evidence demonstrating that low-risk individuals rarely develop postoperative epileptiform events. Therefore, neurosurgeons can safely omit universal anticonvulsant prophylaxis in appropriately selected patients. By transitioning toward tailored perioperative management, surgical teams optimize patient recovery, eliminate drug-induced complications, and improve overall institutional resource utilization. Furthermore, avoiding unnecessary antiepileptic drugs prevents unwanted drug-induced lethargy during the critical initial post-anesthesia recovery phase. As a result, bedside clinicians can perform precise, unimpeded serial neurological assessments. Ultimately, these clinical advantages support a paradigm shift toward selective, individualized perioperative management for low-risk neurosurgical cohorts.

Prospective Cohort Study Design and Noninferiority Framework

To determine whether clinicians can safely omit preventive antiepileptic drugs, investigators conducted a prospective single-center cohort study between January 2019 and June 2023. The trial enrolled adult patients who required microsurgical treatment for unruptured saccular aneurysms. Researchers specifically selected low-risk candidates presenting with lesions measuring less than fifteen millimeters in maximal diameter. Furthermore, the protocol strictly excluded individuals with prior seizures, preexisting structural brain damage, or traumatic parenchymal injury. Throughout the study duration, neurosurgeons performed standard microsurgical neck clipping without administering preoperative or postoperative prophylactic antiepileptic pharmacotherapy. The primary clinical endpoint focused on the occurrence of unprovoked postoperative seizures over a comprehensive one-year follow-up period. Additionally, the research team established a prespecified noninferiority margin of 5.5% using an exact binomial statistical framework. To identify independent predictors of adverse neurological events, statisticians applied both univariable and multivariable Firth penalized logistic regression models. This rigorous analytical approach effectively mitigated small-sample bias and accommodated rare event distributions. Finally, the authors performed internal validation using one thousand bootstrap resamples, ensuring that the resulting clinical risk models maintained outstanding statistical robustness and reproducible accuracy. Moreover, clinical evaluators maintained standardized documentation regarding surgical approaches, operating microscope duration, temporary clipping intervals, and postoperative neuroimaging findings. This meticulous design ensured transparent evaluation of confounding factors that might independently influence epileptogenesis.

Key Findings on Seizure Incidence and Safety Thresholds

The prospective cohort analyzed 428 consecutive adult patients who underwent elective microsurgical intervention. Overall, postoperative seizures developed in only seven patients, representing an overall incidence rate of 1.6%. Statistical evaluation demonstrated an exact two-sided 95% confidence interval ranging from 0.66% to 3.34%. Notably, the upper confidence limit remained substantially below the prespecified noninferiority threshold of 5.5%. A one-sided exact binomial hypothesis test formally confirmed that the observed seizure rate was significantly lower than the noninferiority margin. Consequently, these findings validate the hypothesis that withholding prophylactic antiseizure medications does not expose low-risk surgical patients to excessive clinical risk. Furthermore, most epileptiform events occurred acutely within the initial postoperative week rather than during late outpatient convalescence. Patients who developed early convulsions responded promptly to targeted rescue therapy without developing permanent functional disabilities or status epilepticus. By demonstrating noninferiority, the trial clearly demonstrates that universal chemoprophylaxis provides negligible therapeutic benefit for patients with small, uncomplicated vascular lesions. Thus, selective management represents an effective and safe approach in modern cerebrovascular centers. In addition, long-term functional assessments at twelve months demonstrated excellent neurological recovery across the entire cohort. None of the patients who suffered an isolated postoperative seizure developed chronic drug-resistant epilepsy. Therefore, withholding prophylactic drugs did not compromise long-term neurological integrity or patient quality of life.

Clinical Predictors and Risk Factor Stratification

Although the overall complication rate remained low, identifying individual clinical vulnerabilities is critical for clinical decision-making. Through multivariable Firth penalized logistic regression, investigators determined specific surgical and anatomical characteristics associated with postoperative convulsive episodes. Specifically, extended operative duration, significant intraoperative cortical retraction, and postoperative ischemic changes emerged as notable contributing factors. When surgeons encounter complex vascular geometry requiring prolonged manipulation, localized cortical irritation can occasionally trigger transient focal or generalized epileptiform activity. Similarly, unexpected intraoperative microvascular compromise or localized parenchymal contusions noticeably elevate the baseline seizure threshold. Conversely, patient age, biological sex, and specific anterior circulation locations did not demonstrate independent predictive value in the final regression analysis. Internal bootstrap validation confirmed the stability of these predictive parameters across repeated simulation resamples. Therefore, instead of prescribing prophylactic medications indiscriminately to every patient, clinicians should focus their surveillance on individuals exhibiting complex intraoperative courses. This targeted stratification allows surgical teams to restrict antiepileptic medications exclusively to patients harboring objective surgical challenges or acute postoperative radiologic abnormalities. Additionally, careful review of operative parameters highlighted that excessive brain spatula pressure and prolonged temporary arterial occlusion require heightened clinical suspicion. When surgical teams anticipate these specific operative complexities, they can proactively institute focused post-procedure monitoring rather than subjecting every routine patient to prolonged pharmacological prophylaxis.

Implications for Perioperative Neurocritical Practice

These prospective findings provide an essential rationale for updating contemporary neurosurgical clinical guidelines. Historically, empirical anticonvulsant administration created substantial clinical burdens, including unwanted cognitive sedation and potential hypersensitivity syndromes like Stevens-Johnson syndrome. Moreover, standard anticonvulsants frequently interact with essential cardiovascular therapies, antihypertensive agents, and pain medications commonly administered during neurosurgical recovery. By adopting a restrictive prophylaxis strategy, multidisciplinary teams eliminate unnecessary pharmacological exposure while preserving therapeutic safety. However, adopting this paradigm requires meticulous perioperative neurological monitoring. In modern neurocritical care units, clinicians must remain vigilant for subtle focal motor movements, transient speech disturbances, or acute altered sensorium. If an unexpected seizure occurs, clinicians should administer prompt rescue therapy alongside urgent neuroimaging to rule out underlying structural ischemia or hematoma. Additionally, centers should maintain clear institutional protocols for continuous electroencephalography when patients exhibit delayed awakening. Ultimately, this evidence supports a personalized treatment model, empowering neurosurgeons to withhold routine anticonvulsants in low-risk cohorts while maintaining swift intervention protocols for complicated clinical scenarios. Furthermore, adopting selective protocols lowers hospital pharmacy expenditure and minimizes nursing administration complexities. Multidisciplinary collaboration between neurosurgeons, neurointensivists, and clinical pharmacists ensures smooth transition to post-discharge care. Consequently, institutional guidelines should actively encourage restrictive prophylaxis while enforcing standardized rescue pathways for the rare instances when unexpected seizures occur.

Frequently Asked Questions

Why is seizure prophylaxis often withheld during unruptured aneurysm clipping?

Clinicians withhold routine prophylaxis because postoperative seizure rates in low-risk patients remain exceptionally low at approximately 1.6%. Consequently, routine administration exposes patients to adverse drug reactions, organ toxicities, and drug interactions without offering measurable clinical benefits compared to watchful monitoring and selective rescue therapy.

Which patients undergoing aneurysm surgery face the highest seizure risk?

Patients who experience prolonged operative times, significant brain retraction, intraoperative vascular compromise, or postoperative cerebral infarction carry the greatest seizure risk. Additionally, individuals with preexisting structural brain injuries or previous histories of epilepsy require closer neurological monitoring and individualized anticonvulsant management plans.

What rescue protocols should teams implement if a postoperative seizure occurs?

If an acute seizure occurs, surgical teams should promptly administer fast-acting intravenous anticonvulsants like levetiracetam or lorazepam. Clinicians must also obtain urgent cranial computed tomography or magnetic resonance imaging immediately to exclude acute intracranial hemorrhage, parenchymal contusion, or unexpected microvascular cerebral ischemia.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Ryu BG et al. Incidence of postoperative seizures after clipping of unruptured intracranial aneurysms without prophylactic antiseizure medications: a prospective noninferiority cohort study. Neurosurg Rev. 2026 Aug 04. doi: 10.1007/s10143-026-04431-6. PMID: 42550277.


2. Chung J, Lim Y, Kim B, Lee D, Lee K, Shin Y. Early and late microsurgical clipping for initially coiled intracranial aneurysms. Neuroradiology. 2010;52(12):1123-1130.


3. Baker CJ, Prestigiacomo CJ, Solomon RA. Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery. 1995;37(5):863-870.


4. Moroi J, et al. Perioperative seizures in clipping of unruptured cerebral aneurysms. World Neurosurg. 2017;102:406-411.